Therapy effects of green tea in a patient with systemic light-chain amyloidosis

Clinical Research in Cardiology

Volumn 97, Issue 5, 2008, Pages 341-344

  Mereles, Derliz ^a   Wanker, Erich E ^b   Katus, Hugo A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; EPIGALLOCATECHIN GALLATE; MELPHALAN;

AGED; AMYLOIDOSIS; ANAMNESIS; APOPTOSIS; ARTIFICIAL HEART PACEMAKER; CASE REPORT; DRUG MEGADOSE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEART BLOCK; HEART INFARCTION; HUMAN; LETTER; MALE; PHYSICAL EXAMINATION; TEA;

AGED; AMYLOIDOSIS; CAMELLIA SINENSIS; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; PHYTOTHERAPY; TEA;

EID: 44249124217     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0649-6     Document Type: Letter

References (16)

1. Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Puechal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M; Eprodisate for AA amyloidosis trial group (2007) Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med 356:2349-2360
2. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE (2007). Amyloid remodeling by (-)-epigallocatechin gallate suppresses α-synuclein, amyloid-β toxicity (submitted)
3. Feng WY (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7:755-809
4. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 79:319-328
5. Hunstein WK (2007) Epigallocatechin-3-gallat in AL amyloidosis - a new therapeutic option? Blood 110:2216
6. Koyama J, Ray-Sequin PA, Falk RH (2003) Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446-2452
7. Lambert JD, Kim DH, Zheng R, Yang CS (2006) Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice. J Pharm Pharmacol 58:599-604
8. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP (2007) A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3- gallate as a potential anticancer agent. Cancer Res 67:4303-4310
9. Obregon DF, Rezai-Zadeh K, Bai Y, Sun N, Hou H, Ehrhart J, Zeng J, Mori T, Arendash GW, Shytle D, Town T, Tan J (2006) ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 281:16419-16427
10. Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN (2002) Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 417:254-259
11. Perz JB, Kristen AV, Rahemtulla A, Parameshwar J, Sack FU, Apperley JF, Goldschmidt H, Katus HA, Dengler TJ (2006) Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation. Clin Res Cardiol 95:671-674
12. Rajkumar SV, Gertz MA (2007) Advances in the treatment of amyloidosis. N Engl J Med 356:2413-2415
13. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807-8814
14. Shanafelt TD, Lee YK, Call TG, Nowakowski GS, Dingli D, Zent CS, Kay NE (2006) Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res 30:707-712
15. Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER (1981) M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 63:188-196
16. Vyas S, Sharma M, Sharma PD, Singh TV (2007). Design, semisynthesis, evaluation of O-acyl derivatives of (-)-epigallocatechin-3-gallate as antitumor agents. J Agric Food Chem, July 3. doi: 10.1021/jf070519f